Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP190086.RA2EASjAXicJSJYOq02L6CqGYkOdpJ-Dy8sbirwjL5OHI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP190086.RA2EASjAXicJSJYOq02L6CqGYkOdpJ-Dy8sbirwjL5OHI130_assertion type Assertion NP190086.RA2EASjAXicJSJYOq02L6CqGYkOdpJ-Dy8sbirwjL5OHI130_head.
- NP190086.RA2EASjAXicJSJYOq02L6CqGYkOdpJ-Dy8sbirwjL5OHI130_assertion description "[Concurrent promotor hypermethylation of p16INK4a and p14ARF correlated significantly with tumor size, lymph node metastasis, and stage III/IV advanced OSCC; p14ARF hypermethylation, in particular, was significantly associated with both lymph node metastasis and late clinical stage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP190086.RA2EASjAXicJSJYOq02L6CqGYkOdpJ-Dy8sbirwjL5OHI130_provenance.
- NP190086.RA2EASjAXicJSJYOq02L6CqGYkOdpJ-Dy8sbirwjL5OHI130_assertion evidence source_evidence_literature NP190086.RA2EASjAXicJSJYOq02L6CqGYkOdpJ-Dy8sbirwjL5OHI130_provenance.
- NP190086.RA2EASjAXicJSJYOq02L6CqGYkOdpJ-Dy8sbirwjL5OHI130_assertion SIO_000772 15975525 NP190086.RA2EASjAXicJSJYOq02L6CqGYkOdpJ-Dy8sbirwjL5OHI130_provenance.
- NP190086.RA2EASjAXicJSJYOq02L6CqGYkOdpJ-Dy8sbirwjL5OHI130_assertion wasDerivedFrom befree-20140225 NP190086.RA2EASjAXicJSJYOq02L6CqGYkOdpJ-Dy8sbirwjL5OHI130_provenance.
- NP190086.RA2EASjAXicJSJYOq02L6CqGYkOdpJ-Dy8sbirwjL5OHI130_assertion wasGeneratedBy ECO_0000203 NP190086.RA2EASjAXicJSJYOq02L6CqGYkOdpJ-Dy8sbirwjL5OHI130_provenance.